Eosinophilia during letermovir treatment after allogeneic hematopoietic stem cell transplantation

被引:0
作者
Hiroki Hosoi
Shogo Murata
Toshiki Mushino
Akinori Nishikawa
Takashi Sonoki
机构
[1] Wakayama Medical University,Department of Hematology/Oncology
来源
Annals of Hematology | 2020年 / 99卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2453 / 2454
页数:1
相关论文
共 97 条
[1]  
Goldner T(2011)The novel anticytomegalovirus compound AIC246 (letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase J Virol 85 10884-10893
[2]  
Hewlett G(2013)Investigation of the freely available easy-to-use software 'EZR' for medical statistics Bone Marrow Transplant 48 452-458
[3]  
Ettischer N(2017)Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation N Engl J Med 377 2433-2444
[4]  
Ruebsamen-Schaeff H(2002)Eosinophilia indicates the evolution to acute graft-versus-host disease Blood 100 3055-1800
[5]  
Zimmermann H(2002)Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation Transplantation 74 1797-770
[6]  
Lischka P(2007)Blood eosinophilia as a marker of favorable outcome after allogeneic stem cell transplantation Transpl Int 20 761-1898
[7]  
Kanda Y(2014)Eosinophils from hematopoietic stem cell recipients suppress allogeneic T cell proliferation Biol Blood Marrow Transplant 20 1891-3364
[8]  
Marty FM(2013)CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT Blood 122 3359-1763
[9]  
Ljungman P(2019)The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the infectious diseases working party of EBMT Ann Hematol 98 1755-undefined
[10]  
Chemaly RF(undefined)undefined undefined undefined undefined-undefined